Literature DB >> 23849911

Doctors and pharma in China.

.   

Abstract

Mesh：

Year:  2013        PMID： 23849911     DOI： 10.1016/S0140-6736(13)61547-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  International trials in middle-income countries: different local scenarios require different ethical approaches.

Authors:  Rafael Dal-Ré; Vivekanand Jha; Jicheng Lv; Ranjit Roy Chaudhury; Yongjun Wang; Vlado Perkovic
Journal:  J R Soc Med       Date:  2015-10-02       Impact factor: 5.344

2.  Violence against Doctors: The Class Wars.

Authors:  Sundeep Mishra
Journal:  Indian Heart J       Date:  2015-08-21

Review 3.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

4.  Factors associated with the use of percutaneous coronary intervention in elderly Chinese patients with a first ST elevated acute myocardial infarction.

Authors:  Shan Zhou; Jie Chen; Ru-Yi Xu; Hai-Yun Wu
Journal:  Patient Prefer Adherence       Date:  2014-02-17       Impact factor: 2.711

5.  Moving towards a better path? A mixed-method examination of China's reforms to remedy medical corruption from pharmaceutical firms.

Authors:  Jianwei Shi; Rui Liu; Hua Jiang; Chunxu Wang; Yue Xiao; Nana Liu; Zhaoxin Wang; Leiyu Shi
Journal:  BMJ Open       Date:  2018-02-08       Impact factor: 2.692

6.  Impact of adverse media reporting on public perceptions of the doctor-patient relationship in China: an analysis with propensity score matching method.

Authors:  Jing Sun; Shiyang Liu; Qiannan Liu; Zijuan Wang; Jun Wang; Cecile Jia Hu; Mark Stuntz; Jing Ma; Yuanli Liu
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.